论文部分内容阅读
Aim To evaluate in vivo distribution characteristics of a novel proliposomal preparation of tegafur in rats.Methods Concentrations of tegafur in tissues and plasma were measured by HPLC following intragastric gavage of the proliposomal preparation of tegafur(PL-FT207) or aqueous suspension of tegafur tablet(T-FT207) to rats.And the pharmacokinetic parameters including the area under the concentration-time curve(AUC),relative tissue efficiency and the maximum drug concentration were calculated.Results Following intragastric gavage of PL-FT207 or T-FT207 to rats,AUC was significantly increased in plasma,liver,kidney,colon and lung(P<0.01) of PL-FT207 group in contrast to that of(T-FT207) group,the relative tissue efficiencies of these tissues were 1.36-1.57,the maximum drug concentrations of brain and lung of PL-FT207 group were significantly declined(P<0.005).Conclusion The novel proliposomal preparation of tegafur is able to promote drug absorption in gastro-intestine,increase drug distribution in kidney,liver,colon and lung,and decrease the maximum drug concentration in brain and heart,thus providing scientific basis for further studies on this preparation.
Aim To evaluate in vivo distribution characteristics of a novel proliposomal preparation of tegafur in rats. Methods Concentrations of tegafur in tissues and plasma were measured by HPLC following intragastric gavage of the proliposomal preparation of tegafur (PL-FT207) or aqueous suspension of tegafur tablet ( T-FT207) to rats. And the pharmacokinetic parameters including the area under the concentration-time curve (AUC), relative tissue efficiency and the maximum drug concentration were calculated. Results Following intragastric gavage of PL-FT207 or T-FT207 to rats, AUC was significantly increased in plasma, liver, kidney, colon and lung (P <0.01) of PL-FT207 group in contrast to that of (T-FT207) group, the relative tissue efficiencies of these tissues were 1.36-1.57, the maximum drug concentrations of brain and lung of PL-FT207 groups were significantly declined (P <0.005) .Conclusion The novel proliposomal preparation of tegafur is able to promote drug absorption in gastro-intestine, increase drug dis tribution in kidney, liver, colon and lung, and decrease the maximum drug concentration in brain and heart, thus providing scientific basis for further studies on this preparation.